Passage Bio, Inc. (PASG)
4.52
+0.19
(+4.39%)
USD |
NASDAQ |
Aug 28, 16:00
4.57
+0.05
(+1.11%)
After-Hours: 20:00
Passage Bio 30-Day Average Daily Volume : 19820.77 for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 19820.77 |
| August 27, 2026 | 20938.70 |
| August 26, 2026 | 23008.03 |
| August 25, 2026 | 24725.07 |
| August 24, 2026 | 26002.23 |
| August 21, 2026 | 27858.03 |
| August 20, 2026 | 27961.37 |
| August 19, 2026 | 28231.53 |
| August 18, 2026 | 27983.23 |
| August 17, 2026 | 29985.50 |
| August 14, 2026 | 30296.63 |
| August 13, 2026 | 31711.40 |
| August 12, 2026 | 33516.40 |
| August 11, 2026 | 36290.20 |
| August 10, 2026 | 39865.10 |
| August 07, 2026 | 48592.73 |
| August 06, 2026 | 75038.50 |
| August 05, 2026 | 109517.8 |
| August 04, 2026 | 112359.3 |
| August 03, 2026 | 112353.4 |
| July 31, 2026 | 114557.2 |
| July 30, 2026 | 115078.9 |
| July 29, 2026 | 116759.0 |
| July 28, 2026 | 117768.5 |
| July 27, 2026 | 118279.7 |
| Date | Value |
|---|---|
| July 24, 2026 | 119189.4 |
| July 23, 2026 | 118407.7 |
| July 22, 2026 | 119255.9 |
| July 21, 2026 | 119084.6 |
| July 20, 2026 | 119910.8 |
| July 17, 2026 | 118866.1 |
| July 16, 2026 | 118184.1 |
| July 15, 2026 | 116489.8 |
| July 14, 2026 | 115178.6 |
| July 13, 2026 | 114200.1 |
| July 10, 2026 | 113970.5 |
| July 09, 2026 | 113964.3 |
| July 08, 2026 | 114024.9 |
| July 07, 2026 | 113499.7 |
| July 06, 2026 | 111961.8 |
| July 02, 2026 | 112408.5 |
| July 01, 2026 | 111336.6 |
| June 30, 2026 | 110935.5 |
| June 29, 2026 | 109370.9 |
| June 26, 2026 | 107050.3 |
| June 25, 2026 | 100934.7 |
| June 24, 2026 | 79582.97 |
| June 23, 2026 | 46977.97 |
| June 22, 2026 | 47485.53 |
| June 18, 2026 | 48128.60 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ARS Pharmaceuticals, Inc. | 2.257M |
| ACADIA Pharmaceuticals, Inc. | 1.636M |
| Alnylam Pharmaceuticals, Inc. | 2.050M |
| Anika Therapeutics, Inc. | 117828.7 |
| Savara, Inc. | 1.710M |